T1	Premise 919 1160	Baseline mean IOP for all eyes was 24.5 mm Hg in the SLT group, 24.7 mm Hg in the medical group. Mean IOP (both eyes) at last follow-up was 18.2 mm Hg (6.3 mm Hg reduction) in the SLT arm, 17.7 mm Hg (7.0 mm Hg reduction) in the medical arm.
T2	Claim 1578 1704	These results support the option of SLT as a safe and effective initial therapy in open-angle glaucoma or ocular hypertension.
T3	Premise 1161 1252	By last follow-up, 11% of eyes received additional SLT, 27% required additional medication.
T4	Premise 1253 1344	There was not a statistically significant difference between the SLT and medication groups.
T5	Premise 1345 1415	IOP reduction was similar in both arms after 9 to 12-months follow-up.
R1	Support Arg1:T5 Arg2:T2	
R2	Support Arg1:T3 Arg2:T2	
R3	Support Arg1:T1 Arg2:T2	
